These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26762481)

  • 1. The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
    Liang Z; Li Y; Wang J; Wang D; Wang S; Ma L; Liu H; Yang L; Stone GW; Han Y
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():608-15. PubMed ID: 26762481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials.
    Al-Abdouh A; Mhanna M; Jabri A; Madanat L; Alhuneafat L; Mostafa MR; Kundu A; Gupta V
    Cardiovasc Revasc Med; 2024 Apr; 61():52-61. PubMed ID: 37872022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis.
    Zhang J; Chen Z; Wang D; Li C; Luo F; He Y
    Cardiol J; 2024; 31(2):309-320. PubMed ID: 37964648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis.
    Mushahid H; Shah SA; Farhan SH; Shuja MH; Balasingam K; Siddiqui AA; Hameed I; Akram K; Mushahid S; Usman MS
    Am J Cardiovasc Drugs; 2024 May; 24(3):385-398. PubMed ID: 38683263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of bivalirudin versus heparin(s) during percutaneous coronary interventions in patients receiving prasugrel: a propensity-matched study.
    Hamon M; Bonello L; Marso S; Rao SV; Valgimigli M; Verheugt F; Gershlick A; Wang Y; Prats J; Steg GP; Deliargyris E
    Clin Cardiol; 2014 Jan; 37(1):14-20. PubMed ID: 24114942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study.
    Hu YC; Yao WJ; Jin DX; Zhang JX; Wang L; Zhang R; Xu JH; Cong HL
    Medicine (Baltimore); 2021 Mar; 100(10):e25003. PubMed ID: 33725878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention.
    Rajab F; Mujahid A; Naseer B
    Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):263-264. PubMed ID: 38285615
    [No Abstract]   [Full Text] [Related]  

  • 8. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial.
    Yan Y; Guo J; Wang X; Wang G; Fan Z; Yin D; Wang Z; Zhang F; Tian C; Gong W; Liu J; Lu J; Li Y; Ma C; Vicaut E; Montalescot G; Nie S;
    Circulation; 2024 Apr; 149(16):1258-1267. PubMed ID: 38406848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin Versus Heparin Monotherapy in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Study-level Meta-analysis of Randomized Controlled Trials.
    Sun B; Chen RR
    Cardiovasc Drugs Ther; 2024 Jul; ():. PubMed ID: 39080125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Outcomes in Patients Requiring Mechanical Circulatory Support Who Received Cangrelor in Addition to Anticoagulation Versus Anticoagulation Alone.
    Martin TC; Duewell BE; Juul JJ; Rinka JRG; Rein L; Feih JT
    J Cardiothorac Vasc Anesth; 2024 Jun; 38(6):1328-1336. PubMed ID: 38521630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Year Safety and Effectiveness of Bivalirudin
    Li J; Li Y; Su S; Wang Z; Liu H; Yang W; Qiao S; Yang Y; Xu B; Gao R; Yuan J; Zhao X
    Rev Cardiovasc Med; 2023 Aug; 24(8):218. PubMed ID: 39076722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.
    Schüpke S; Hein-Rothweiler R; Mayer K; Janisch M; Sibbing D; Ndrepepa G; Hilz R; Laugwitz KL; Bernlochner I; Gschwendtner S; Kupka D; Gori T; Zeiher AM; Schunkert H; Massberg S; Kastrati A;
    Thromb Haemost; 2019 Sep; 119(9):1539-1545. PubMed ID: 31226721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Bivalirudin and Ordinary Heparin on the Incidence of Bleeding Events and the Level of Inflammation after Interventional Therapy for Acute Myocardial Infarction.
    Wu Q; Xie T; Chen Y; Zhou Y; Han X
    Altern Ther Health Med; 2024 May; ():. PubMed ID: 38814607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia.
    Sukumaran M; Cantrell DR; D'Agostino C; Jahromi BS; Ansari SA; Potts MB
    J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107310. PubMed ID: 38636321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART Score.
    Simonsson M; Winell H; Olsson H; Szummer K; Alfredsson J; Hall M; Dondo TB; Gale CP; Jernberg T
    J Am Heart Assoc; 2019 Mar; 8(5):e012157. PubMed ID: 30803289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Duration of Diabetes Mellitus on Long-Term Outcome in Type 2 Diabetic Patients with Primary Percutaneous Coronary Intervention after the First Myocardial Infarction.
    Yaliqin N; Aimaier S; Adi D; Ma YT; Yu ZX
    Cardiology; 2024; 149(4):297-313. PubMed ID: 38763137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Bivalirudin versus unfractionated heparin in acute myocardial infarction: Why are we still debating?
    Cohen M; Sohal S
    Cardiovasc Revasc Med; 2024 Apr; 61():62-63. PubMed ID: 37980264
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply: Pretreatment with unfractionated heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?
    Emilsson OL; Koul S
    EuroIntervention; 2023 Apr; 18(17):1473-1474. PubMed ID: 37092267
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of bivalirudin on myocardial microcirculation and adverse events after interventional therapy in older patients with acute coronary syndrome.
    Du YK; Cui LJ; Gao HB
    World J Clin Cases; 2024 Aug; 12(22):4890-4896. PubMed ID: 39109044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
    Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.